QUALYS INC
For the period ended Sep 30, 2024. Filed Nov 5, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Nov 5, 2024
QLYS$175.11-13.5%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
| Nine Months EndedSeptember 30, | ||
|---|---|---|
| 2024 | 2023 | |
| Cash flow from operating activities: | ||
| Net income | $129,715 | $111,002 |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||
| Depreciation and amortization expense | 14,410 | 21,140 |
| Provision for credit losses | 411 | 230 |
| Loss on non-marketable securities | — | 533 |
| Stock-based compensation, net of amounts capitalized | 56,454 | 50,560 |
| Accretion of discount on marketable securities, net | (5,231) | (3,502) |
| Deferred income taxes | (15,374) | (11,561) |
| Changes in operating assets and liabilities: | ||
| Accounts receivable | 30,848 | 18,137 |
| Prepaid expenses and other assets | (9,900) | (4,804) |
| Accounts payable | 391 | (1,428) |
| Accrued liabilities and other noncurrent liabilities | (1,351) | 8,211 |
| Deferred revenues | (4,001) | 22,248 |
| Net cash provided by operating activities | 196,372 | 210,766 |
| Cash flow from investing activities: | ||
| Purchases of marketable securities | (305,952) | (252,438) |
| Sales and maturities of marketable securities | 252,940 | 212,202 |
| Purchases of property and equipment | (6,497) | (7,263) |
| Net cash used in investing activities | (59,509) | (47,499) |
| Cash flow from financing activities: | ||
| Repurchase of common stock | (97,188) | (147,725) |
| Proceeds from exercise of stock options | 8,311 | 28,384 |
| Payments for taxes related to net share settlement of equity awards | (23,093) | (14,998) |
| Proceeds from issuance of common stock through employee stock purchase plan | 6,872 | 6,077 |
| Payment of acquisition-related holdback | (1,500) | — |
| Net cash used in financing activities | (106,598) | (128,262) |
| Net increase in cash, cash equivalents and restricted cash | 30,265 | 35,005 |
| Cash, cash equivalents and restricted cash at beginning of period | 206,365 | 176,419 |
| Cash, cash equivalents and restricted cash at end of period | $236,630 | $211,424 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.